(S)-tert-Butyl 2-cyclopropylpiperazine-1-carboxylate

Catalog No. :
ACBXRQ257
CAS No. :
1240586-17-7
Molecular Formula :
C12H22N2O2
Molecular Weight :
226.32

IUPAC Name:tert-butyl (S)-2-cyclopropylpiperazine-1-carboxylate

(S)-tert-Butyl 2-cyclopropylpiperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$115.00Login to see priceIn stockInquiry
100mg98%$179.00Login to see priceIn stockIn stock
250mg98%$252.00Login to see priceIn stockIn stock
1g98%$748.00Login to see priceIn stockIn stock
5g98%$3628.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl 2-cyclopropylpiperazine-1-carboxylate
IUPAC Nametert-butyl (S)-2-cyclopropylpiperazine-1-carboxylate
MDL No.MFCD08686636
Molecular FormulaC12H22N2O2
Molecular Weight226.32
SMILESO=C(N1[C@@H](C2CC2)CNCC1)OC(C)(C)C
InChI KeyWRKIMEBHYLJNGY-SNVBAGLBSA-N
Synonym1240586-17-7 | tert-butyl (2S)-2-cyclopropylpiperazine-1-carboxylate | (S)-TERT-BUTYL 2-CYCLOPROPYLPIPERAZINE-1-CARBOXYLATE | 1-Piperazinecarboxylic acid, 2-cyclopropyl-, 1,1-dimethylethyl ester, (2S)- | MFCD08686636 | SCHEMBL16908312 | 1-Boc-(2S)-2-Cyclopropylpipera
CAS No.1240586-17-7
PubChem CID72210722

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBXRQ257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBXRQ257 route product structure diagram
    ACBXRQ2571240586-17-7 In Stock
Inquiry

2. ACBXRQ257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBXRQ257 route product structure diagram
    ACBXRQ2571240586-17-7 In Stock
Inquiry

Comments (0)